[Latest] Global Machinery and Industrial Automation Market Size/Share Worth USD 407.4 Billion by 2032 at a 8.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
January 30, 2024 14:30 ET
|
Custom Market Insights
Austin, TX, USA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Machinery and Industrial Automation Market Size, Trends and Insights By Industry...
Automated Guided Vehicle Market in Middle East & Africa Expected to Surge, Reaching US$ 471.06 Million by 2030
January 21, 2024 21:18 ET
|
Research and Markets
Dublin, Jan. 21, 2024 (GLOBE NEWSWIRE) -- The "Middle East & Africa Automated Guided Vehicle Market Forecast to 2030 - Regional Analysis - by Technology, Vehicle Type, and End User" report has...
$106.55 Billion ADAS Market by Type, Automation Level, Component, Vehicle, End Use, and Geography - Global Forecast to 2030
January 16, 2024 06:33 ET
|
Research and Markets
Dublin, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The "ADAS Market by Type, Automation, Component, Vehicle, End Use, and Geography - Global Forecast to 2030" report has been added to ...
$60.13B Predictive Maintenance Industry Assessment, 2023-2030: Lucrative Segments and Key Player Strategies Unveiled
January 11, 2024 12:48 ET
|
Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Predictive Maintenance Market Size, Share & Trends Analysis Report By Component, By Solution, By Service, By Deployment, By Enterprise Size, By...
Arch Biopartners Receives Health Canada Approval to Conduct Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
January 10, 2024 07:26 ET
|
Arch Biopartners
TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it has received a No Objection Letter from...
US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Halting Neurodegeneration as Leading Treatment Priority
January 03, 2024 09:46 ET
|
Spherix Global Insights
EXTON, PA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Huntington’s disease (HD) could be called the perfect storm of neurodegenerative diseases. It causes a loss of critical striatal neurons which affect not...
Arch Biopartners Receives Approval from the Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
January 03, 2024 07:33 ET
|
Arch Biopartners
TORONTO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it has received approval in Turkey from the...
Global Manufacturing Execution Systems (MES) Strategic Analysis Report 2023: Market to Reach $42.2 Billion by 2030 - MES with Big Data, IoT Capabilities Make a Cut in Digital Transformation Strategies
December 14, 2023 06:23 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Manufacturing Execution Systems (MES) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global...
U.S. Neurologists Eagerly Await Promising Oral Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis Treatment Pipeline, Though Recent Trial Readouts Might Hamper Initial Excitement
December 13, 2023 14:03 ET
|
Spherix Global Insights
Exton, PA, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Several clinical trials are underway for Bruton’s tyrosine kinase inhibitors (BTKi) targeting relapsing and progressive multiple sclerosis (RMS/PPMS)....
ShapeTX Expands Strategic Collaboration with Roche with Addition of a New Target
November 30, 2023 08:00 ET
|
Shape Therapeutics, Inc.
ShapeTX announces the expansion of its drug discovery partnership with Roche with new target